Group items tagged

Saving Lives at Birth: A Grand Challenge for Development, a joint initiative of the United States Agency for International Development, the government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and Britain's Department for International Development, is seeking proposals for groundbreaking prevention and treatment approaches aimed at assisting women and their newborns in poor, hard-to-reach communities around the globe. Through this fourth round of funding, the program will support interventions that increase access to primary health care for women and newborns by at least 50 percent, substantially improve the quality of care as measured by health outcomes, and lead to improved and sustained healthy behavior.

The purpose of this Notice of Funding Opportunity (NOFO) is to reduce risky alcohol use among women of childbearing age through system-level implementation of alcohol screening and brief intervention (SBI) in health systems providing women’s health services. Risky alcohol use can result in a variety of negative health and social consequences, such as motor vehicle crashes, intimate partner violence, and fetal alcohol spectrum disorders. It is costly, results in over 88,000 deaths annually, and can affect serious medical conditions, such as hypertension, liver disease and certain types of cancer. Health professionals are uniquely positioned to intervene with patients with acute and chronic health conditions caused or exacerbated by risky alcohol use. Alcohol SBI implementation efforts within health systems will focus on development and implementation of: a training and technical assistance plan; alcohol SBI protocols in primary care clinics; system-level approaches that facilitate uptake (e.g., electronic health record integration and performance metrics); an evaluation plan assessing feasibility and impact of system-level implementation; a dissemination plan on promising models and lessons learned; and a sustainability plan. Expected performance outcomes include documenting provider/clinic readiness to conduct alcohol SBI, documenting implementation barriers and proposed solutions, tracking clinic-level data on alcohol SBI, and assessing the use of system-level strategies.

Woman to Woman, a program of the Ovarian Cancer Research Fund Alliance, pairs gynecologic cancer patients with trained survivor-volunteers who provide one-on-one emotional support and mentoring to women when they need it most. From the moment of diagnosis through the end of treatment, Woman to Woman survivor-volunteers have helped hundreds of women and their families cope with gynecologic cancer. Through the program, one-year grants of either $60,000 (for hospital-based programs) or $30,000 (for community-based organizations) will be awarded to institutions with a large volume of gynecologic cancer patients and a need to provide this type of support to patients. Grants are provided to cover the cost of a part-time program coordinator's salary (can be a new hire or a reassignment), program costs, and a patient fund (no indirect costs allowed). It is expected that each Woman to Woman program will become self-sustaining after the first year. OCRFA will provide all program materials for patients, as well as technical assistance and support, for the life of the program (even after the end of the grant period). Institutions and organizations also will have access to a dedicated section of the Woman to Woman website (under construction) featuring tools designed to assist them in the development and administration of new programs.

The purpose of this funding opportunity announcement (FOA) is to stimulate investigations including translational, epidemiologic and clinical studies and trials that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. NICHD is committed to supporting research that will increase scientific understanding of and treatments for high-priority perinatal infections.

The goal of this NOFO is to provide comprehensive HIV services in Zambia to the general population in areas of high HIV prevalence; and priority populations (PPs), including people living with HIV (PLHIV), adolescent girls and young women (AGYW), men, couples, pregnant women, prisoners, and key populations (KPs). Services to be provided will include: community-based HIV testing services (HTS); HIV prevention services (risk reduction counseling,gender norms, and links to post gender-based violence (GBV) care); TB prevention and treatment, and community based antiretroviral therapy (ART). These services will be linked with community health care facilities. The recipient(s) will work closely with the relevant District Medical Offices (DMOs) selected in consultation with CDC Zambia. To ensure efficiencies and program effectiveness, this NOFO will support activities that complement activities supported by the Zambian government and partners with full transition to the local districts by the end of year five.

The purpose of this initiative is to support health services, intervention, and implementation research to understand and reduce racial/ethnic, geographic, and socioeconomic HIV disparities in US women. Projects may address HIV prevention, screening and diagnosis, and/or treatment. Projects may involve primary data collection and/or secondary analysis of existing data.

The goal of this funding opportunity is to translate and adapt knowledge from around the world to the United States on approaches that can improve health or the determinants of health by improving gender equity. In the United States, determinants of health relate to personal safety, economic opportunity, education access (post-secondary or beyond), supportive workplace and social environments, and protection from bias and discrimination for vulnerable groups. Specifically, we seek to learn from initiatives underway outside the United States whose effectiveness is supported or suggested by empirical evidence and that have the potential to be adapted and implemented in the United States. Some examples of approaches of interest are those that aim to: - Achieve pay equity; - Provide supports in the workplace or other social environments for pregnant women, parents and families; - Counteract cultural stereotypes or expectations that bias women and girls toward low-wage careers or health-damaging jobs or roles; - Address norms, practices, and resources in ways that reduce gender-based violence, aggression, or harassment; - Modify social expectations that promote risky behaviors or contribute to poor mental health; - Build on frameworks about gender, power, and health from groups around the world who have unique traditions and practices related to gender norms and roles; - Create opportunities for gender minorities to make decisions that affect their lives and communities, and to emerge as leaders in government and other positions of influence; or - Apply nonbinary interpretations of gender in policymaking, resource allocation, or service provision.

This initiative aims to: (1) enhance our understanding of the multi-level factors that influence HIV prevention strategy use among adolescent girls and young women (AGYW) in sub-Saharan Africa and (2) develop and test novel interventions to address these factors and enhance the uptake and adherence to HIV prevention strategies among AGYW in sub-Saharan Africa.  The goal of this initiative is to look at the multiple levels of influence on AGYW's behavior from the individual level, to her partners, family members and peers as well as cultural, social norms and structural factors that may influence uptake and adherence to prevention strategies.     

The purpose of this announcement is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods for both men and women.  This FOA expands the scope of the former program by calling for Centers to inform contraceptive development and improve contraceptive use by integrating the biomedical research and development with behavioral and social science research, e.g., demography and other population sciences, psychology, economics, and sociology.  These Centers also will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.

The purpose of this announcement is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods for both men and women.  This FOA expands the scope of the former program by calling for Centers to inform contraceptive development and improve contraceptive use by integrating the biomedical research and development with behavioral and social science research, e.g., demography and other population sciences, psychology, economics, and sociology.  These Centers also will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.

The purpose of this Funding Opportunity Announcement (FOA) is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought.

The purpose of this Funding Opportunity Announcement (FOA) is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought.

The purpose of this Funding Opportunity Announcement (FOA) is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought.

The purpose of this funding opportunity announcement (FOA) is to stimulate investigations including translational, epidemiologic and clinical studies and trials that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding.

This Notice of Funding Opportunity (NOFO) will support a randomized controlled trial (RCT) to evaluate the effectiveness of adult immunization quality improvement interventions to increase influenza and Tdap vaccination coverage among pregnant women in at least two gynecologic/obstetric (OB/GYN) practices (that stock influenza and Tdap vaccines) within a large health system in one or more state, local, or territorial public health jurisdiction(s).

The Foundation for Women's Wellness, a nonprofit charity dedicated to improving women's health by raising support for innovative early stage research and education, is accepting Letters of Inquiry for small short-term studies with potential for improving medical knowledge in the area of women's health. Through the FWW Research Awards program, the foundation will award grants of up to $25,000 for research projects, with an emphasis on cardiovascular disease, female cancers, the role of hormones in disease, and/or stage-of-life health concerns such as pregnancy and menopause and diseases disproportionately affecting women. This may include disease prevention or treatment; clarification of gender differences; and/or quality-of-life concerns. Priority will be given to projects or studies that have direct clinical application in preventing and/or treating disease, and have the potential to yield results that will attract larger sources of funding for further study and/or influence long-term research and clinical care directions. To be eligible, lead investigators must be an MD and/or PhD with a faculty appointment at an accredited medical institution in the United States. In addition, the affiliated institution must accept the award on the awardee's behalf (with no administrative costs deducted). LOIs must be received no later than June 20. Upon review, selected applicants will be invited to submit a full application. See the Foundation for Women's Wellness website for complete program guidelines and application instructions.

The Foundation for Women's Wellness, a nonprofit charity dedicated to improving women's health by raising support for innovative early stage research and education, is accepting Letters of Inquiry for small short-term studies with potential for improving medical knowledge in the area of women's health. Through the FWW Research Awards program, the foundation will award grants of up to $25,000 for research projects, with an emphasis on cardiovascular disease, female cancers, the role of hormones in disease, and/or stage-of-life health concerns such as pregnancy and menopause and diseases disproportionately affecting women. This may include disease prevention or treatment; clarification of gender differences; and/or quality-of-life concerns. Priority will be given to projects or studies that have direct clinical application in preventing and/or treating disease, and have the potential to yield results that will attract larger sources of funding for further study and/or influence long-term research and clinical care directions. To be eligible, lead investigators must be an MD and/or PhD with a faculty appointment at an accredited medical institution in the United States. In addition, the affiliated institution must accept the award on the awardee's behalf (with no administrative costs deducted).

The goal of this FOA is to enhance the diversity of the drug abuse research workforce by providing dissertation awards on topics related to the study of basic and clinical neuroscience, development, epidemiology, prevention, treatment, services, or women and sex/gender differences as they relate to drug abuse. This support will enhance the pool of highly talented drug abuse scientists who conduct research within the funding priority areas (http://www.drugabuse.gov/funding/funding-priorities) or in the NIDA strategic plan (https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan). Applications are encouraged from doctoral candidates in a variety of academic disciplines and programs. This program will ultimately facilitate the entry of promising new investigators into the field of drug abuse research and promote transdisciplinary collaborations. This award is for up to two years of support for the completion of the doctoral dissertation research project.

The goal of this FOA is to enhance the diversity of the drug abuse research workforce by providing dissertation awards on topics related to the study of basic and clinical neuroscience, development, epidemiology, prevention, treatment, services, or women and sex/gender differences as they relate to drug abuse. This support will enhance the pool of highly talented drug abuse scientists who conduct research within the funding priority areas (http://www.drugabuse.gov/funding/funding-priorities) or in the NIDA strategic plan (https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan). Applications are encouraged from doctoral candidates in a variety of academic disciplines and programs. This program will ultimately facilitate the entry of promising new investigators into the field of drug abuse research and promote transdisciplinary collaborations. This award is for up to two years of support for the completion of the doctoral dissertation research project.

The ORWH and participating organizations and institutes seek applications for Specialized Centers of Research Excellence (SCORE) on Sex Differences. The Centers of Excellence will support interdisciplinary approaches to advance translational research on sex differences. Each SCORE institution should develop a research agenda bridging basic and clinical research underlying a health issue that is pertinent to improving the health of women.

The Office of Research on Women's Health (ORWH) announces the availability of administrative supplements to support interdisciplinary, transdisciplinary and multidisciplinary research focused on the effect of sex/gender influences at the intersection of a number of social determinants, including but not limited to: race/ethnicity, socioeconomic status, education, health literacy and other social determinants in human health and illness. This research includes preclinical, clinical and behavioral studies with the specific purpose to provide Administrative Supplements to active NIH parent grants for one year to address health disparities among women of populations in the US who are understudied, underrepresented and underreported in biomedical research.

This funding opportunity announcement (FOA) invites applications from U.S. institutions to support Research Units (RUs) within the Global Network for Womens and Childrens Health Research at NICHD. RUs will consist of U.S.-based research centers applying in partnership with research centers in low income countries as defined by the World Bank. The RUs within the Global Network will participate in addressing the major causes of maternal, neonatal, infant, and early childhood morbidity and mortality through the conduct of clinical research. The grantees will become part of a cooperative network in scientific partnership with the NIH to conduct multi-enter observational studies and randomized clinical trials evaluating disease process, health and wellness outcomes, and results from interventions in resource-poor settings.